• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. MCRYL+ VIO 27IN 2-0 S/A SH; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. MCRYL+ VIO 27IN 2-0 S/A SH; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Catalog Number MCP317H
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/01/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a patient underwent an unknown procedure on an unknown date and suture was used.It was reported by the distributor that needles are defected.Last 3 time the needle comes apart from the suture.No adverse impact was reported.Device is available for return.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 3/17/2026.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: ten product complaints were created to document 10 different cases: (b)(4) is created for 1st event (mcp942g/ 103930).(b)(4) is created for 2nd event (mcp987h/ uamrce).(b)(4) is created for 3rd event (mcp987h/ 102czu).(b)(4) is created for 4th event (mcp317h/ umbkhd).(b)(4) is created for 5th event (mcp987h/ 103cp2).(b)(4) is created for 6th event (mcp942g/ tlmcht).(b)(4) is created for 7th event (mcp315h/ tgmppt).(b)(4) is created for 8th event (mcp942g/ ubmqqj).(b)(4) is created for 9th event (497g/ spbclq).(b)(4) is created for 10th event (z969h/ 109ls).Please provide the following information for each case: it was reported that "last 3 time the needle comes apart from the suture".* did all the reported devices have this issue? if no, please porvide additional details.* when did the alleged deficiency occur (removal from package / during handling prior to use on patient/ during passage through tissue / during tying / post-op)? if different, please explain.* is this device or samples from same lot available for analysis? if yes, to whom should the shipper kit be sent? (please provide contact name, department, street address including zip, no po box please, email address, and phone number) * credit was requested.Please provide a copy of the ethicon invoice to complete this request.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.The following information was reported: ¿ we have not removed this issue to ethicon before now.¿ all 10 products referenced are associated with separate events.D4: udi: the expiration date is currently not available.Therefore, the full udi is currently not available.
 
Additional Manufacturer Narrative
Product complaint: (b)(4).Date sent to the fda: 4/17/2026.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H6 component code: g07002 pending evaluation of returned device.Additional information: d4 (expiration dte, udi), d9, h3, h4, h6.Corrected information: d1, d4 (product code).A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.A device has been received, however it has not yet been evaluated.Any further information derived from the evaluation will be submitted in a supplemental 3500a form.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 5/4/2026 this report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H6 component code: g07002 no device problem found additional information: d9, h3, h6 a manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.H3 investigational summary: the product was returned to ethicon for evaluation.Visual inspection revealed that three sealed boxes each with thirty-six unopened samples were received for analysis.Product code mcp987h.As per the sampling plan, a visual inspection was performed on thirty-two samples, and the packets were opened.The swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along the strand no anomalies were observed during evaluation.The functional test was performed using instron equipment and the pull force result was above the minimum requirements.As part of eth quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as the device performed without any difficulties noted.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MCRYL+ VIO 27IN 2-0 S/A SH
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
calle durango #2751
ciudad juarez 32575
MX   32575
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
3035526892
MDR Report Key24619172
Report Number2210968-2026-02725
Device Sequence Number18600325
Product Code GAM
UDI-Device Identifier10705031046375
UDI-Public(01)10705031046375(17)260131(10)UBMQQJ
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
K050845
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Distributor
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2026
Device Catalogue NumberMCP317H
Device Lot NumberUBMQQJ
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/18/2026
Supplement Date Received by Manufacturer04/01/2026
05/04/2026
Initial Report FDA Received Date03/17/2026
Supplement Report FDA Received Date04/17/2026
05/04/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/27/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-